Faruqi & Faruqi Announces Investigation of Merck & Co Over Potential Securities Law Violations

Faruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline Approaching

New York, NY - Faruqi & Faruqi, a leading national securities law firm, reminds investors of the pending class action lawsuit against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK). The lawsuit is brought on behalf of all persons and entities who purchased or acquired Merck's securities between March 5, 2020 and April 6, 2022, inclusive (the "Class Period").

The lawsuit was filed in the United States District Court for the District of New Jersey, and the lead plaintiff deadline is approaching. If you are a current or former investor in Merck's securities, you may be affected by this lawsuit and are encouraged to contact Faruqi & Faruqi to learn more about your potential legal remedies.

The lawsuit alleges that Merck and certain of its officers and/or directors made false and/or misleading statements and/or failed to disclose material information, violating federal securities laws. Specifically, the lawsuit alleges that Merck and its executives made false and/or misleading statements regarding the Company's COVID-19 vaccine, Vaxzevria, and its development timeline, as well as the Company's financial performance and guidance.

On April 6, 2022, Merck announced that it would be delaying the development of its COVID-19 vaccine, Vaxzevria, due to concerns over the vaccine's safety and efficacy. This news caused Merck's stock price to plummet, damaging investors.

Faruqi & Faruqi is a leading national securities law firm with decades of experience fighting for the rights of investors in cases of corporate fraud and other misconduct. The firm's litigation team is experienced in handling complex securities cases, and has a proven track record of success in recovering losses for investors.

If you are a current or former investor in Merck's securities, you may be able to recover your losses by participating in this class action lawsuit. Faruqi & Faruqi encourages you to contact them to learn more about your potential legal remedies.

Contact Faruqi & Faruqi at info@faruqilaw.com or 1-877-247-4292 to learn more about the lawsuit and your potential legal remedies. You can also visit the firm's website at www.faruqilaw.com for more information.